FDA clears kit for monitoring molecular response in CMLJuly 26, 2016Leukemia, Myelodysplasia, TransplantationCML
Delirium in advanced cancer may go undetectedJuly 25, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Blood disorders prove costly for European economyJuly 22, 2016CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaThrombosisBlood Banking
Ibrutinib approved for first-line treatment of CLLJuly 21, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Radiologists no longer have higher risk of cancer-related deathJuly 21, 2016AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLMyelodysplastic Syndrome
BTK inhibitor may treat ibrutinib-resistant cancersJuly 20, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
FDA rejects pegfilgrastim biosimilarJuly 20, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Antimalarials, antifungals may fight leukemiaJuly 20, 2016Leukemia, Myelodysplasia, TransplantationAMLALL
Weight loss lowers levels of cancer-associated proteinsJuly 15, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaBlood BankingRelated Issues
Cancer patients and docs disagree about prognosisJuly 15, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
FDA lifts hold on phase 2 JCAR015 trialJuly 14, 2016Leukemia, Myelodysplasia, TransplantationPharmacyALL
